Analyst Recommendations

Jefferies analyst issues BUY recommendation for AVAV on March 2, 2026 09:21PM ET. The previous analyst recommendation was Buy.AVAV was trading at $208.32 at issue of the analyst...

March 2, 2026   AVAV -4.71%

Raymond James analyst issues UNDERPERFORM recommendation for AVAV on March 2, 2026 03:41PM ET. The previous analyst recommendation was Strong Buy.AVAV was trading at $202.98 at issue of...

March 2, 2026   AVAV -4.71%

Piper Sandler analyst issues OVERWEIGHT recommendation for CRWD on March 2, 2026 05:44AM ET. The previous analyst recommendation was Neutral.CRWD was trading at $371.98 at issue of the...

March 2, 2026   CRWD -4.92%

Macquarie analyst issues OUTPERFORM recommendation for BIDU on February 26, 2026 07:45PM ET. The previous analyst recommendation was Outperform.BIDU was trading at $125.15 at issue of the analyst...

February 26, 2026   BIDU -1.58%

Wolfe Research analyst issues UNDERPERFORM recommendation for AI on February 26, 2026 01:03PM ET. The previous analyst recommendation was Underperform.AI was trading at $8.48 at issue of the...

February 26, 2026   AI -4.53%

UBS analyst issues REDUCE recommendation for AI on February 26, 2026 01:13PM ET. The previous analyst recommendation was Reduce.AI was trading at $8.445 at issue of the analyst...

February 26, 2026   AI -4.53%

Itau BBA analyst issues MARKET PERFORM recommendation for NVDA on February 26, 2026 03:15PM ET. The previous analyst recommendation was Market Perform.NVDA was trading at $186.581 at issue...

February 26, 2026   NVDA -0.25%

Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for CRM on February 26, 2026 02:59PM ET. The previous analyst recommendation was Overweight.CRM was trading at $198.02 at issue of the...

February 26, 2026   CRM -6.18%

Cowen & Co. analyst issues BUY recommendation for NVDA on February 26, 2026 03:17PM ET. The previous analyst recommendation was Buy.NVDA was trading at $186.855 at issue of...

February 26, 2026   NVDA -0.25%

BTIG analyst issues BUY recommendation for CRM on February 26, 2026 11:15AM ET. The previous analyst recommendation was Buy.CRM was trading at $191.75 at issue of the analyst...

February 26, 2026   CRM -6.18%